---
title: "Incannex Healthcare (IXHL) news: going concern and offering"
url: "https://aibio.space/companies/incannex-healthcare/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "IXHL going concern, offering and Nasdaq notice news: Incannex Healthcare Inc. gets Nasdaq minimum bid price notice, has until October 20, 2025."
---

IXHL Incannex Healthcare Inc. NASDAQ · Australia

# Incannex Healthcare (IXHL) news IXHL going concern, offering and Nasdaq notice news

Financings · 2025-07-24

## [Incannex Healthcare adds up to $100,000,000 to at-the-market stock program](https://aibio.space/news/incannex-healthcare-adds-up-100-000-000-market-stock-program/)

Incannex had already sold about $63,469,250 of stock under the program. A week later it said it has no plans to use the full capacity in the near term.

## Latest Incannex Healthcare news

1. 2025-06-13 Listings [Incannex Healthcare applies to move its listing to the Nasdaq Capital Market](https://aibio.space/news/incannex-healthcare-applies-move-listing-nasdaq-capital-market/) The transfer from the Nasdaq Global Market is part of the company's effort to meet Nasdaq continued listing requirements. Shares would keep trading as IXHL.
2. 2025-04-25 Listings [Incannex Healthcare Inc. gets Nasdaq minimum bid price notice, has until October 20, 2025](https://aibio.space/news/incannex-healthcare-inc-gets-nasdaq-minimum-bid-price-notice-has-until/) Nasdaq told Incannex on April 23, 2025 that its shares had closed below $1.00 for 30 consecutive trading days, giving it until October 20, 2025 to regain compliance. Its annual report for the year ended June 30, 2024 carries an auditor's going concern paragraph.
3. 2025-01-10 Listings [Incannex gets Nasdaq deficiency notice on $50.0 million market value requirement](https://aibio.space/news/incannex-gets-nasdaq-deficiency-notice-50-0-million-market-value/) Incannex Healthcare received a Nasdaq notice on January 3, 2025 that its market value of listed securities fell below the $50.0 million minimum for the Global Market. It has until July 2, 2025 to regain compliance, and its 2024 annual report carries a going-concern warning with $5.6 million of cash at June 30, 2024.

## Incannex Healthcare at a glance

- **Ticker**: IXHL

- **Listing**: NASDAQ

- **Country**: Australia

- **Cash, Jun 30, 2026**: $67.7 million

### Related companies

- [Cynata Therapeutics](https://aibio.space/companies/cynata-therapeutics/) ASX: CYP
- [Ceryvyn Therapeutics](https://aibio.space/companies/ceryvyn-therapeutics/) ASX: CYV
- [Propanc Biopharma](https://aibio.space/companies/propanc-biopharma/) NASDAQ: PPCB
- [Invex Therapeutics](https://aibio.space/companies/invex-therapeutics/) ASX: IXC
- [Biotron](https://aibio.space/companies/biotron/) ASX: BIT
- [Polynovo](https://aibio.space/companies/polynovo/) ASX: PNV
- [LTR Pharma](https://aibio.space/companies/ltr-pharma/) ASX: LTP
- [Holista Colltech](https://aibio.space/companies/holista-colltech/) ASX: HCT

### Also on NASDAQ

- [Vericel](https://aibio.space/companies/vericel/) VCEL
- [SS Innovations International](https://aibio.space/companies/ss-innovations-international/) SSII
- [Adial Pharmaceuticals](https://aibio.space/companies/adial-pharmaceuticals/) ADIL
- [Vyome Holdings](https://aibio.space/companies/vyome/) HIND
- [Nexalin Technology](https://aibio.space/companies/nexalin-technology/) NXL
- [Sanara MedTech](https://aibio.space/companies/sanara-medtech/) SMTI

## Incannex Healthcare annual financials

| Line | FY ended Jun 30, 2026 | FY ended Jun 30, 2025 |
|---|---|---|
| Research and development | [$5.2 million](https://www.sec.gov/Archives/edgar/data/1873875/000162828026063506/) | [$10.7 million](https://www.sec.gov/Archives/edgar/data/1873875/000162828026063506/) |
| Net income (loss) | [-$19.3 million](https://www.sec.gov/Archives/edgar/data/1873875/000162828026063506/) | [-$46.9 million](https://www.sec.gov/Archives/edgar/data/1873875/000162828026063506/) |
| Cash from operations | [-$12.9 million](https://www.sec.gov/Archives/edgar/data/1873875/000162828026063506/) | [-$12.5 million](https://www.sec.gov/Archives/edgar/data/1873875/000162828026063506/) |
| Cash and equivalents | [$67.7 million](https://www.sec.gov/Archives/edgar/data/1873875/000162828026063506/) | [$15.0 million](https://www.sec.gov/Archives/edgar/data/1873875/000162828026063506/) |

Latest balance sheet, Jun 30, 2026 (10-K): cash and equivalents $67.7 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

## Questions about Incannex Healthcare

Has Incannex Healthcare issued a going-concern warning?

Our latest story on this, dated Apr 25, 2025: "Incannex Healthcare Inc. gets Nasdaq minimum bid price notice, has until October 20, 2025". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/incannex-healthcare-inc-gets-nasdaq-minimum-bid-price-notice-has-until/).

Has Incannex Healthcare raised money recently?

Our latest story on this, dated Jul 24, 2025: "Incannex Healthcare adds up to $100,000,000 to at-the-market stock program". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/incannex-healthcare-adds-up-100-000-000-market-stock-program/).

Has Incannex Healthcare received a Nasdaq deficiency notice?

Our latest story on this, dated Jan 10, 2025: "Incannex gets Nasdaq deficiency notice on $50.0 million market value requirement". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/incannex-gets-nasdaq-deficiency-notice-50-0-million-market-value/).

What is the ticker symbol of Incannex Healthcare?

Incannex Healthcare Inc. trades under the ticker IXHL on NASDAQ.

Where is Incannex Healthcare listed?

Incannex Healthcare Inc. is listed on NASDAQ.

What is the SEC CIK of Incannex Healthcare?

The SEC Central Index Key (CIK) for Incannex Healthcare Inc. is 1873875. Its filings are on SEC EDGAR.

How many shares does Incannex Healthcare have outstanding?

12,544,627 shares as of 2026-09-24, per the cover page of its 10-K filed 2026-09-25.

Which country or territory is Incannex Healthcare listed under?

Our directory records Incannex Healthcare Inc. under Australia.

What does Incannex Healthcare do?

Our directory classifies Incannex Healthcare Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Incannex Healthcare?

The ISIN recorded for Incannex Healthcare Inc. is US45333F2083.

Does aibio.space cover Incannex Healthcare?

aibio.space lists Incannex Healthcare Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Where is Incannex Healthcare incorporated?

SEC records list its state or country of incorporation as DE.

Is Incannex Healthcare profitable?

Incannex Healthcare Inc. reported a net loss of $19.3 million for the fiscal year ended Jun 30, 2026, and used $12.9 million of cash in operations, per its annual report to the SEC.

How much does Incannex Healthcare spend on research and development?

$5.2 million in the fiscal year ended Jun 30, 2026, per its annual report.

How much cash does Incannex Healthcare have?

$67.7 million in cash at Jun 30, 2026, per its 10-K.

## Investor discussion: Incannex Healthcare

Members talk about Incannex Healthcare (IXHL). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Incannex Healthcare, newest first. Each line links the filing it comes from.

1. 2026-09-25 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-K. [Source](https://www.sec.gov/Archives/edgar/data/1873875/000162828026063506/ixhl-20260630.htm)
2. 2026-03-27 Financings Announced a share repurchase program. SEC Form 8-K (Items 7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390026035161/ea028374201ex99-1.htm)
3. 2026-03-18 Financings Announced a share repurchase program. SEC Form 8-K (Items 7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390026029761/ea028228801ex99-1.htm)
4. 2026-03-17 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390026028661/ea028100001ex99-1.htm)
5. 2026-03-12 Distress Reported the end of a material agreement. SEC Form 8-K (Items 1.02,7.01,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390026026644/ea027841501ex99-1.htm)
6. 2026-03-12 Financings Reported a financing. SEC Form 8-K (Items 1.01,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390026026645/ea027829601ex99-1.htm)
7. 2026-02-25 Listings Reported a reverse stock split. SEC Form 8-K (Items 3.03,5.03,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390026020127/ea027810901ex99-1_incannex.htm)
8. 2026-01-29 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390026009160/ea027453901ex99-1_incannex.htm)
9. 2026-01-22 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390026006448/ea027369501ex99-1_incannex.htm)
10. 2026-01-14 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390026004158/ea027288301ex99-1_incannex.htm)
11. 2025-10-30 Financings Reported a financing. SEC Form 8-K (Items 8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390025103780/ea026276501ex99-1_incannex.htm)
12. 2025-10-22 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390025100980/ea0262074-8k_incannex.htm)
13. 2025-08-22 Financings Announced a share repurchase program. SEC Form 8-K (Items 8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390025079600/ea025412501ex99-1_incannex.htm)
14. 2025-07-24 Financings Reported a financing. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390025067368/ea0250049-424b5_incannex.htm)
15. 2025-06-13 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390025053995/ea0245512-8k_incannex.htm)
16. 2025-06-12 Financings Reported a financing. SEC Form 8-K (Items 8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390025053588/ea024539601ex99-1_incannex.htm)
17. 2025-05-28 Financings Reported a financing. SEC Form 8-K (Items 1.01,1.02,5.02,5.03,5.07,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390025047988/ea0243459-8k_incannex.htm)
18. 2025-05-15 Financings Reported a financing. SEC Form 8-K (Items 8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390025043706/ea024232901ex99-1_incannex.htm)
19. 2025-04-28 Listings Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390025036057/ea0239657-01.htm)
20. 2025-04-25 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,8.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390025035636/ea0239610-8k_incannex.htm)
21. 2025-04-07 Financings Reported a financing. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390025029414/ea0237318-424b5_incannex.htm)
22. 2025-03-18 Listings Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390025024754/ea0234680-pre14a_incannex.htm)
23. 2025-03-10 Financings Reported a financing. SEC Form 8-K (Items 1.01,3.02,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390025022279/ea023369701ex99-1_incannex.htm)
24. 2025-01-10 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). [Source](https://www.sec.gov/Archives/edgar/data/1873875/000121390025002666/ea0227297-8k_incannex.htm)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:IXHL on TradingView](https://www.tradingview.com/symbols/NASDAQ-IXHL/).

## SEC filings and registration

- **SEC name**: Incannex Healthcare Inc.

- **CIK**: 1873875

- **Industry (SIC)**: Pharmaceutical Preparations (2834)

- **US tickers**: IXHL (Nasdaq)

- **State or country of incorporation**: DE

- **Fiscal year ends**: June 30

- **Filer category**: Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

- **Business address**: 8 CENTURY CIRCUIT, NORWEST NSW

- **Phone**: 61 409 840 786

- **Shares outstanding**: 12,544,627 as of 2026-09-24 (10-K filed 2026-09-25)

- **Former names**: Incannex Healthcare Ltd

### Recent filings (8-K and 6-K are the company's own announcements)

- [10-K](https://www.sec.gov/Archives/edgar/data/1873875/000162828026063506/ixhl-20260630.htm) filed 2026-09-25
- [8-K](https://www.sec.gov/Archives/edgar/data/1873875/000121390026098213/ea0304782-8k_incannex.htm) filed 2026-09-09
- [8-K](https://www.sec.gov/Archives/edgar/data/1873875/000121390026093244/ea0303140-8k_incannex.htm) filed 2026-08-25
- [8-K](https://www.sec.gov/Archives/edgar/data/1873875/000121390026087493/ea0301333-8k_incannex.htm) filed 2026-08-11
- [8-K](https://www.sec.gov/Archives/edgar/data/1873875/000121390026080622/ea0298674-8k_incannex.htm) filed 2026-07-23
- [8-K](https://www.sec.gov/Archives/edgar/data/1873875/000121390026071745/ea0295769-8k_incannex.htm) filed 2026-06-25
- [8-K](https://www.sec.gov/Archives/edgar/data/1873875/000121390026067081/ea0293917-8k_incannex.htm) filed 2026-06-10
- [8-K](https://www.sec.gov/Archives/edgar/data/1873875/000121390026066526/ea0293934-8k_incannex.htm) filed 2026-06-09

Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001873875), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.

## Listing details

Incannex Healthcare Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker IXHL, recorded under Australia. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: Incannex Healthcare Inc.

- **Ticker**: IXHL

- **Listing**: NASDAQ

- **Country or territory**: Australia

- **Business scope**: Biotechnology

- **ISIN**: US45333F2083

- **Last quote in directory**: 2026-10-21

- **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-IXHL/)

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/incannex-healthcare/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Incannex Healthcare (IXHL) news: going concern and offering", 2026-10-31, https://aibio.space/companies/incannex-healthcare/